Barrington Research reissued their buy rating on shares of Healthequity (NASDAQ:HQY) in a research note published on Monday, AnalystRatings.com reports. The brokerage currently has a $75.00 price target on the stock.
Several other analysts have also recently weighed in on HQY. Deutsche Bank started coverage on Healthequity in a research report on Thursday, September 12th. They set a buy rating and a $74.00 price objective on the stock. Oppenheimer dropped their price target on Healthequity from $98.00 to $76.00 and set an outperform rating on the stock in a research report on Wednesday, September 4th. SunTrust Banks lowered their price objective on Healthequity to $80.00 and set a buy rating for the company in a research report on Monday, September 9th. Wells Fargo & Co dropped their target price on shares of Healthequity from $80.00 to $76.00 and set an outperformer rating on the stock in a report on Wednesday, September 4th. Finally, TheStreet cut shares of Healthequity from a b rating to a c+ rating in a report on Tuesday, September 3rd. Three analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. The stock presently has an average rating of Buy and an average target price of $77.00.
Shares of HQY stock opened at $61.54 on Monday. The company has a market capitalization of $4.44 billion, a P/E ratio of 64.78, a PEG ratio of 2.87 and a beta of 1.47. Healthequity has a fifty-two week low of $50.29 and a fifty-two week high of $91.79. The company has a debt-to-equity ratio of 0.04, a quick ratio of 22.98 and a current ratio of 22.98. The stock has a 50 day moving average price of $59.64 and a two-hundred day moving average price of $64.25.
In other news, CFO Darcy G. Mott sold 4,000 shares of the stock in a transaction on Wednesday, November 20th. The stock was sold at an average price of $60.39, for a total value of $241,560.00. Following the sale, the chief financial officer now directly owns 38,000 shares of the company’s stock, valued at $2,294,820. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders sold 12,000 shares of company stock worth $715,600 over the last three months. Corporate insiders own 3.70% of the company’s stock.
A number of hedge funds and other institutional investors have recently made changes to their positions in HQY. Oregon Public Employees Retirement Fund boosted its holdings in shares of Healthequity by 1.4% during the 2nd quarter. Oregon Public Employees Retirement Fund now owns 22,031 shares of the company’s stock valued at $1,441,000 after acquiring an additional 310 shares during the last quarter. AE Wealth Management LLC grew its position in Healthequity by 64.2% in the 2nd quarter. AE Wealth Management LLC now owns 6,903 shares of the company’s stock worth $451,000 after purchasing an additional 2,700 shares during the period. NJ State Employees Deferred Compensation Plan bought a new stake in Healthequity in the 2nd quarter worth approximately $327,000. First Quadrant L P CA grew its position in Healthequity by 398.4% in the 2nd quarter. First Quadrant L P CA now owns 15,027 shares of the company’s stock worth $983,000 after purchasing an additional 12,012 shares during the period. Finally, Arizona State Retirement System raised its stake in Healthequity by 1.6% during the 2nd quarter. Arizona State Retirement System now owns 39,606 shares of the company’s stock valued at $2,590,000 after buying an additional 631 shares during the last quarter. Institutional investors own 95.84% of the company’s stock.
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Story: How a Strangle Strategy is different from a Straddle Strategy
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.